Skip to content

Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010

Observational Study on the Outcome of Patients With Primary Immune Thrombocytopenia (ITP) Who Underwent Splenectomy After January 1st, 2010

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06466824
Enrollment
157
Registered
2024-06-20
Start date
2024-09-30
Completion date
2025-03-31
Last updated
2024-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Immune Thrombocytopenia

Keywords

splenectomy

Brief summary

Retrospective data collection on ITP patients who underwent splenectomy from 01/01/2010 to 12/31/2022. The expected enrollment period is 6 months. The observation period of the enrolled patients is at least 1 year.

Detailed description

Observational, longitudinal, retrospective study on ITP patients. Patients with ITP who underwent splenectomy from 01/01/2010 to 12/31/2022 will be enrolled. All useful data will be collected exclusively through consultation of outpatient medical records. The expected enrollment period is 6 months. The observation period of the enrolled patients is at least 1 year.

Interventions

None listed

Sponsors

Gruppo Italiano Malattie EMatologiche dell'Adulto
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged ≥ 18 years * Patients with primary ITP according to international criteria \[2\], who underwent to splenectomy from 01/01/2010 to 12/31/2022. * Obtaining Informed Consent.

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
evaluation of complications' incidence after splenectomyat 90 daysDetermine the percentage and incidence of thrombotic, hemorrhagic and infectious complications occurring during the patient's follow-up

Contacts

Primary ContactPaola Fazi
p.fazi@gimema.it0670390528
Backup ContactEnrico Crea
e.crea@gimema.it0670390514

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026